Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
396 Leser
Artikel bewerten:
(1)

Scepter Holdings, Inc., anticipates introduction of Fisetin infused sprays developed by Gevitta, LLC

Gevitta LLC has developed Fisetin supplement spray formulas

LAS VEGAS, NV / ACCESSWIRE / January 31, 2020 / Scepter Holdings, Inc., (OTC PINK:BRZL) a high-performance consumer goods sales and marketing company, anticipates introduction of Fisetin infused supplement spray formulations.

Gevitta, LLC has completed the development of Fisetin infused supplement spray formulations to be marketed by Scepter Holdings along with existing Gevitta branded supplement sprays. Fisetin, a plant polyphenol present in many fruits and vegetables, such as strawberries and apples, and has shown anti-cancer activity in lab studies1. Gevitta, LLC pursued the formulation of a Fisetin infused supplement in response to research indicating it may help protect cells from stress-related damage, allowing them to perform at full their potential. In studies, Fisetin appears to help regulate inflammatory pathways and deactivates several major inflammatory compounds.2

"Gevitta, LLC excels at developing formulas and delivery systems ahead of consumer demand. We anticipate interest in fisetin-infused supplements will only continue to grow." stated Robert Van Boerum, Chairman of the Board.

Scepter Holdings maintains licenses to market and distribute Gevitta branded products. The Company looks forward to introducing fisetin-infused supplements for sale online alongside other Gevitta branded products on Gevitta.com and Amazon.com.

1Syed, DN; et al. (Sep 2013). "Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetin". Anticancer Agents Med Chem. .

2Gupta, SC; et al. (1 October 2014). "Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols". Archives of Biochemistry and Biophysics.

About Scepter Holdings, Inc.

Scepter Holdings, Inc. (the "Company") manages the sales and brand development of high-performance consumer packaged goods. The company seeks to acquire performing brands to add to the company's portfolio of products and brands sold online and through strategic retail relationships. The company has expertise manufacturing, distributing, marketing, and selling online consumer packaged goods and seeks to leverage its expertise to grow additional acquired brands. Scepter Holdings, Inc. was incorporated under the laws of the State of Nevada on January 11, 2007.

For more information, please visit our website: http://scepterbrands.com

Forward-Looking Statements

This news release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including economic slowdown affecting companies, our ability to successfully develop products, rapid change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Scepter Holdings, Inc. filings with the Securities and Exchange Commission, which factors may be incorporated herein by reference. Forward-looking statements may be identified but not limited by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.

Investors Contact:
775-296-5768

info@scepterbrands.com

SOURCE: Scepter Holdings, Inc.



View source version on accesswire.com:
https://www.accesswire.com/574629/Scepter-Holdings-Inc-anticipates-introduction-of-Fisetin-infused-sprays-developed-by-Gevitta-LLC

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2020 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.